RECENT NEWS

In July 2019, the Department of Health and Social Care asked the GMC to regulate physician associates (PAs) and anaesthesia associates (AAs). Opinion on these roles continues to be divided. Are these professions undervalued and unfairly undermined, or do these titles cause confusion and/or create the potential for risk? CSJ wants your views…

Getinge has donated extensive medical equipment to Ukraine. The donation, made in collaboration with the Ministry of Health Ukraine, includes a significant number of anaesthesia machines and ventilators, aimed at directly improving healthcare and increasing the country's resilience against the challenges of war.

The National Institute for Health and Care Research (NIHR) has launched a new global health funding stream to support global health researchers in low and middle income countries (LMICs).

The NHS is stepping up a national campaign to recruit former members of the Armed Forces who want to join the health service and offer their valuable skills to caring for patients.

Researchers at the University of Oxford, the Francis Crick Institute and University College London have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine.

Thousands of people could be set to benefit after NICE recommended a new one-a-day pill as an option for treating severe ulcerative colitis.

Tens of thousands of children and adults living with type 1 diabetes across England are set to receive an ‘artificial pancreas’ in a world-first initiative being rolled out by the NHS.

The government will provide funding for over 27,000 more healthcare workers in England to receive two one-off payments - worth at least £1,655 and up to £3,000.

​Nuffield Health Exeter Hospital has performed its 2,000th surgery with the Mako robot, which enables consultant surgeons to carry out more precise knee and hip replacements, with patients likely to experience less pain and faster recoveries.

Public satisfaction with the NHS has fallen to the lowest level ever recorded, according to analysis of the latest British Social Attitudes survey (BSA) published by The King’s Fund and the Nuffield Trust.

Action is needed to tackle the persistence of blame cultures and fears of speaking up in the NHS, says Patient Safety Learning.

People at risk should be tested for atrial fibrillation every time they attend a health appointment, according to results of the AFFECT-EU project. Patients at high risk of the disorder, such as those with heart failure or prior stroke, should be invited for a screening test.

Professor Andrew Morris CBE FRSE FMedSci has been elected as the next President of the Academy of Medical Sciences. He will succeed Professor Dame Anne Johnson DBE PMedSci, taking up the role from 25 April 2024.

An NIHR funded report has explored how 'virtual wards' can work optimally to treat people at high risk of - or experiencing - a frailty crisis.

Researchers have taken a major step towards identifying millions of ‘silent spreaders’ of tuberculosis.

Patients with lung disease are more likely to develop heart disease independent of any risk factors, according to new research.

People living in poverty find it harder to live a healthy life, live with greater illness, face barriers to accessing timely treatment, and die earlier than the rest of the population, says analysis from The King’s Fund health and care think tank.

​A blood test which could help thousands of people receive earlier, more targeted, lung cancer treatments is being trialled by the NHS. The circulating tumour DNA (ctDNA) test, which will be offered to 10,000 patients by next March, can identify genetic variants in a tumour through a simple blood sample.

Researchers from the University of Birmingham have received funding from Cancer Research UK and the Engineering and Physical Sciences Research Council to create a new ‘lollipop’ diagnostic for mouth cancer using a novel smart hydrogel.

UK start-up Presymptom Health has raised £1.5m in follow-on seed and grant funding that will help accelerate time to market of its AI-driven sepsis and infection tests - with the company aiming to roll-out its technology to the NHS from mid-2025.